MASK MASK
Company Profile ↓Company Overview
MASK (MASK) is a publicly traded company listed on with a market capitalization of $661.50K. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Return on capital employed stands at 30.0%.
Net profit has compounded at 20.3% per year over the last five years.
Revenue has grown at a 55.1% CAGR over the past five years.
Trades at an undemanding P/E of 0.8.
Maintains a net profit margin of 15.8%.
Carries low leverage with a debt-to-equity ratio of 0.20.
Recent Developments
- Jun 2025 Revenue of $4.84M (+462.7% YoY); net profit $764.92K.
- Trailing 12 Months Year-on-year growth — revenue +462.7%, earnings -50.6%.
- 5-Year Trend Long-term compounding — revenue CAGR 55.1%, profit CAGR 20.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 55.08% |
| 1 Year: | 462.66% |
Compounded Profit Growth
| 5 Years: | 20.30% |
| 1 Year: | -50.60% |
Stock Price Performance
| 1 Year: | -94.45% |
| 6 Months: | -73.98% |
| 3 Months: | -29.67% |
| 1 Month: | -23.83% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)38.40 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Healthy ROCE of 30.0%.
- Compounding revenue at 55.1% over 5 years.
- Profit CAGR of 20.3% over 5 years.
- Generates positive free cash flow.
CONS
- Trading 94.5% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Revenue | 1.30M | 37.13K | 859.34K | 4.84M |
| Cost of Revenue | 423.62K | 7.34K | 30.90K | 2.43M |
| Gross Profit | 872.75K | 29.79K | 828.45K | 2.41M |
| Operating Expenses | 384.46K | 11.76K | 10.89K | 478.42K |
| Operating Income | 488.30K | 18.03K | 817.56K | 1.93M |
| EBITDA | 515.96K | 18.03K | 817.56K | 1.93M |
| Interest Expense | - | - | - | - |
| Pretax Income | 488.71K | 15.79K | 817.56K | 1.91M |
| Tax Provision | 49.31K | 1.77K | 114.96K | 431.14K |
| Net Income | 439.40K | 996.16K | 1.55M | 764.92K |
| Diluted EPS | 0.85 | 2.50 | 3.75 | 1.75 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Total Assets | 1.79M | 2.01M | 3.86M | 9.36M |
| Current Assets | 983.12K | 946.71K | 2.22M | 7.19M |
| Cash & Equivalents | 46.77K | 19.40K | 11.12K | 313.57K |
| Inventory | - | - | - | - |
| Receivables | 886.32K | 875.28K | 540.00K | 3.22M |
| Total Liabilities | 1.50M | 812.87K | 1.12M | 4.00M |
| Current Liabilities | 1.09M | 261.00K | 1.12M | 2.92M |
| Long Term Debt | 404.98K | 551.87K | 402.20K | 1.08M |
| Total Debt | 404.98K | 551.87K | 402.20K | 1.08M |
| Total Equity | 298.31K | 1.20M | 2.74M | 5.35M |
| Shares Outstanding | 450.00K | 450.00K | 450.00K | 450.00K |
Cash Flows (Annual)
Figures in USD.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Operating Cash Flow | 973.59K | 901.29K | 929.20K | 13.83K |
| Investing Cash Flow | -35.41K | -11.48K | 0 | -2.95M |
| Financing Cash Flow | -910.92K | -871.49K | -888.93K | 3.17M |
| Capital Expenditure | -35.41K | -11.48K | - | - |
| Free Cash Flow | 938.18K | 901.29K | 929.20K | 13.83K |
| Net Change in Cash | 27.26K | 18.32K | 40.27K | 232.55K |
Ratios (Annual)
Figures in %.
| Metric | Jun 2022 | Jun 2023 | Jun 2024 | Jun 2025 |
|---|---|---|---|---|
| Gross Margin % | 67.3% | 80.2% | 96.4% | 49.8% |
| Operating Margin % | 37.7% | 48.6% | 95.1% | 39.9% |
| Net Margin % | 33.9% | 2,682.9% | 180.2% | 15.8% |
| ROE % | 147.3% | 83.3% | 56.6% | 14.3% |
| ROCE % | 69.4% | 1.0% | 29.9% | 30.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for MASK
Why MASK Stock Is Ripping Higher In Pre-Market Today? - Stocktwits
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxPblFNendOVU1ub2dZbDZBZEVoNm1MZkpjbjJLQlFQN3k2WG8xMHRsYkw1S2VvZ2IzblE5SWdrZ0xqLU53UWYtVnY4TTdxaWQ5dEFTanluNlp5WWNhZ2szWVRKcl9RUFdfMWFTYmljVzQ2ZHhzSUhJVzk0eXBQb3NHblB3Mm44eHg2M1hlNz…
Extreme Earnings Forecasts Mask Stock Market Risk - Hussman Funds
<a href="https://news.google.com/rss/articles/CBMiW0FVX3lxTFBjZy12N09tX3NYQlNKM1FYZ1pvRkFCTGRmckVBZ3ZCOU9ONEJtSmI4aTZxaWdBTGhnbW5yMHJPYnpqQVZuOFItRDFpR0lBWmxiM1MxdWJ5YmFUd1E?oc=5" target="_blank">Extreme Earnings Forecasts Mask Stock Market…
3 E Network Technology (MASK) News Flow - Moomoo
<a href="https://news.google.com/rss/articles/CBMi2gJBVV95cUxQSWdsVEs1aWt6ZFoyODA4aWJDZkRZcVNlZzlqUWZXNUFxUDR4LW0xRTJGdm9kUlVERVl2YnA0b251aEdZODJsRTVibjVlRVFIbUdZZG5Hb0I0TVdwSENWYmJSVnNROUgzU0NSOXNROTNzdmo0WjZQeEJtWHdFRzhRVjd0eGRwNFJTWVdmaF…
Constellation Brands: Beer Growth and Buybacks Mask Stock's Slump - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxOTnYzQ09mbXVKYnFmcmtuSFBBRUFzTjRfNmRCeVJmYUdtR1lLbXJudTFLUlFkTkw4WjJwcnFvNlRBRDNyLUY5aVppNE1XTUJUMzVtOWxLclFNYmZmaktzcnVFQlhOLU93UXhPZC1nZWJzYkJQdXg4TDdNeHYtUDM2eXphYmFDM1c1cVg3NH…
Mirion Technologies (MIR) Stock Falls As Acquisitions Mask Modest Organic Growth - webull.com
<a href="https://news.google.com/rss/articles/CBMiWEFVX3lxTE1oaFpfY2ZTQmNmYldtd0NfdktodjhXbWdWaGxNU1NiUXJlbnBPeDgyMzhabElPdXhwWDctZjBEemhGZGNhdUdlYm5QSHpkLWxTVzZ4NGU2NHI?oc=5" target="_blank">Mirion Technologies (MIR) Stock Falls As Acquisi…
How 3 E Network wants to power eldercare robots with edge AI - Stock Titan
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxOeUxfcVBLejMyMjFMcDVIOTRoNnVUVHZIWnU3TkV0NkxvZjZvYXphMm9vc29pSDJIWnpOUkNLaUI5ekJxSHFVWUY5Um5vT3MtRXMyZzdKS01EeGpWN3NjMFJjekRzZjNsNTZPMWpPTEdEWE9saWVYV1JrRndvdDBNcDdiVWFOVHZHeXVYYn…
MASK — Frequently Asked Questions
What is the current share price of MASK?
As of 2026-08-05 17:25 PDT, MASK trades at $1.47 on NASDAQ/NYSE. Its 52-week range is $1.24 to $26.50.
What is the market capitalisation of MASK?
MASK has a market capitalisation of $661.50K on NASDAQ/NYSE.
What is the P/E ratio of MASK?
MASK trades at a trailing price-to-earnings (P/E) ratio of 0.84. Its price-to-book (P/B) ratio is 0.12.
What is the return on equity (ROE) of MASK?
MASK has a return on equity (ROE) of 14.29%. Its return on capital employed (ROCE) is 30.01%.
Is MASK a good stock to buy?
This page provides a data-driven analysis of MASK, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.